SNS Insider projects the global spray polyurethane foam market to grow from USD 2.77B in 2025 to USD 5.07B by 2035 at a 6.34% CAGR. Closed-cell SPF leads with ~48% share. Cold-chain and food-logistics insulation are accelerating fastest, with pharmaceutical cold-chain SPF adoption growing 6.8% per year.
Closed-cell SPF carries the higher-performance roof, exterior wall, foundation and cold-chain segments — anywhere a low-permeance, structural-rated, dimensionally stable insulation is required. Open-cell SPF tends to fill the residential interior, sound-attenuation and budget retrofit segments. The roughly 48/52 split cited reflects geographic mix as much as application mix; the US weighs heavily towards closed-cell, parts of Europe and Asia carry more open-cell.
The strongest growth segment cited — pharmaceutical cold-chain SPF at +6.8% per year — points at where new spec work is most active. Pharma cold-chain demands tight thermal envelopes around critical temperature ranges, and SPF is well-suited where conventional panel construction is impractical or where retrofitting an existing structure is the project.